Hall, Adrian <br/><br/>
Discovery of sodium 6-[(5-chloro-2-phenyl)methyl]-2-pyridinecarboxylate (GSK269984A) an EP(1) receptor antagonist for the treatment of inflammatory pain.  [electronic resource] 

 -  Bioorganic & medicinal chemistry letters  May 2009 
 - 2599-603 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1464-3405 
<br/><br/><label>Standard No.: </label>10.1016/j.bmcl.2009.02.112  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analgesics--chemical synthesis<br/>Animals<br/>Central Nervous System--drug effects<br/>Chemistry, Pharmaceutical--methods<br/>Drug Design<br/>Humans<br/>Hydrogen-Ion Concentration<br/>Inflammation--drug therapy<br/>Inhibitory Concentration 50<br/>Models, Chemical<br/>Nicotinic Acids--chemical synthesis<br/>Pyridines--chemical synthesis<br/>Rats<br/>Receptors, Prostaglandin E--antagonists & inhibitors<br/>Structure-Activity Relationship